• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Will PAR South Huntsville Site Shuts down or be Sold Off?

  • Shutdown

    Votes: 0 0.0%
  • Sold Off

    Votes: 0 0.0%
  • Or be used used to make minimal beer money for executives

    Votes: 0 0.0%

  • Total voters
    0
  • Poll closed .
Not sure who Bob is, but he had some bald-headed fool with him. He asked all kinds of question with no clue of what he was talking about, and he is a senior leader from Chestnut Ridge.
 




You guys let me know when you want me to come back. I made a huge mistake purchasing PAR and for that i am deeply sorry. I brought them in to the ENDO Family and i can take them out.

Regards, Rajiv
 












































I heard we will be moving one of the high-speed tablet packaging lines to the liquids facility and PAR plans to keep that plant. They still plan to sell the distribution center and the tablets plant.
 












I heard we will be moving one of the high-speed tablet packaging lines to the liquids facility and PAR plans to keep that plant. They still plan to sell the distribution center and the tablets plant.

Think about this for a second...Why would a solid dosage packaging line be moved to liquids? Yeah, no reason at all.
 








Confirmed by corporate. Ranbaxy is getting the first look. They want to break back into commodities where they have a strong marketing presence. Martin Skreli is rumored to be the next CEO at Ranbaxy and has expressed an interest. My information is correct. I won't disappoint.
 








Mike Randolph didn't do shit to help anyone but himself. He lied to everyone at Par Huntsville, telling them there would be no shutdown or layoffs. This was only a couple months before the shutdown was announced. Somebody remove his head from Paul C's ass.